The enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313
COVID-19 Impact on the Global Enteric disease testing Market
The concern among consumers is estimated to increase for the security and safety of food products due to the outbreak of COVID-19, and this might lead to a high adoption rate for testing technologies and laboratories across the globe. Thus, the demand for enteric disease testing will increase in the coming years. Moreover, pandemic situations created due to the outbreak of COVID-19 will increase the demand for rapid tests from food manufacturers and growers to test an adequate number of samples in less time, thereby increasing the supply chain activities and enhancing the adoption of testing technologies.
Driver: Increase in demand for convenience foods
Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to accentuate the organoleptic characteristics of food & beverages. Packaged products are also added with preservatives to improve their shelf life. With the increase in preference for convenience foods, the need for enteric disease testing is growing.
Restraint: Lack of proper regulations governing pathogen testing in the developing economies
The food industry in developing countries remains highly fragmented and is predominated by small and unorganized players, who may have not necessarily adopted proper food testing practices, leading to a greater risk of contamination. The testing of food & beverage products, such as packaged foods, dairy products, beverages, and meat products, requires proper enforcement measures, coordination between market stakeholders, and supporting infrastructure. However, many countries that are classified in the cluster of developing economies lack these factors, acting as a restraint to the testing of pathogens in food and water in these regions.
The food segment is estimated to account for the fastest growth in the by end use segment for the enteric disease testing market.
The increase in food trade has encouraged public health and government agencies to continuously monitor food quality and take prompt actions to identify, contain, and correct sources of outbreaks. For instance, the Enteric disease and Inspection Service (FSIS) has framed regulations to control the contamination of meat & poultry products in slaughterhouses and processing plants, based on the HACCP enteric disease control system.
By technology, the rapid technology segment is estimated to account for the largest market share in the enteric disease testing market.
Rapid technology in the food industry is used to monitor the count, type, and metabolites of microorganisms that lead to food spoilage, preservation, fermentation, safety, and foodborne pathogens As the use of the Hazard Analysis & Critical Control Points (HACCP) model and other enteric disease systems have become firmly entrenched in quality assurance/quality control (QA/QC) programs, the industry’s need for “faster, better, cheaper” real-time test results has also increased.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139763313
The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period
The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.
Key Market Players:
Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.
No comments:
Post a Comment